Investing Profile

Matthew Rizzo

InvestorVC
Partner at Orbimed
orbimed.comNew York, New York
Photo of Matthew Rizzo, Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
12
$18B
CompanyStageDateRound SizeTotal Raised
Nucleus RadioPharma
Private EquityApr 2026$50M
$110M
Co-investors: Justin Butler (Eclipse Ventures)
Airstrip Technologies
Debt FinancingOct 2025$50M
$110M
Co-investors: Michael Dixon (Transformation Capital)
vVardis
Series UnknownJul 2025$50M
Series UnknownFeb 2025$35M
$85M
Koya Medical
Series CNov 2023$30M
$70M
Co-investors: Jan Garfinkle (Arboretum Ventures), Eric Kwan (Locus Ventures)
Evozyne
Series BSep 2023$81M
$81M
Cellipont Bioservices
Debt FinancingMar 2023
Co-investors: Conrad Wang (OrbiMed)
Insmed
Post Ipo DebtOct 2022$500M
$500M
Adaptive Biotechnologies
Post Ipo DebtSep 2022$130M
$130M